# Junta clínica — PT-pseudo_aed2e170b8e6 (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_aed2e170b8e6",
  "pid": "PT-pseudo_aed2e170b8e6",
  "task": 1,
  "psa": 86.0,
  "age": 73,
  "months": 1,
  "pirads": "5",
  "psad": 2.306,
  "psav": 14.92,
  "psap": 57.4,
  "vol": 37.29,
  "dre": "Nodus",
  "bx": "Positive",
  "cspca": 0.9527162,
  "medhx": "Not reported",
  "meds": "None",
  "notes": "PSA 86 ng/mL. PI-RADS 5. PSAD 2.31. Prostate volume 37 mL. DRE nodus. csPCa 0.95.",
  "pmhx": [],
  "allergies": [],
  "vitals": {
    "weight": "84 kg",
    "height": "181 cm",
    "bmi": "25.6",
    "bp": "111/74 mmHg",
    "hr": "72 bpm",
    "smoking": "Non-smoker",
    "last_dental": "1 yr ago",
    "flu_vax": "Oct 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "12 Jan 2025",
  "enc_ref": "Dr. R. van den Berg (GP)",
  "enc_type": "Re-evaluation - prior PCa diagnosis",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Specialist assessment required after confirmed malignancy and subsequent PSA elevation."
    },
    {
      "s": "History",
      "t": "A 73-year-old warehouse manager seeks specialist guidance following prolonged urological tracking. He is married and resides in an independent unit within a retirement community. He is a non-smoker. Lower urinary tract complaints remain minimal, yielding a 4/35 IPSS score. Despite significant anxiety surrounding invasive diagnostics, he requests thorough consultations. His medical history contains no comorbidities, and he takes no active medication, aside from a minor knee arthroscopy more than ten years ago and a recent dermatology check for actinic keratosis monitoring. He explicitly denies bone discomfort, unexplained weight reduction, or blood in the urine."
    },
    {
      "s": "Physical examination",
      "t": "DRE — texture: firm; mobility: fixed; asymmetry: palpable nodus in the right lobe. The remaining abdominal and cardiovascular survey shows no anomalies. Vital signs record 111/74 mmHg with a steady pulse of 72 bpm. He demonstrates adequate perfusion and preserves standard functional capacity."
    }
  ],
  "occupation": "warehouse manager",
  "marital": "Married",
  "living": "Lives in retirement community (independent unit)",
  "next_of_kin": "Adult son (primary contact)",
  "recent_other": [
    "Dermatology — actinic keratosis check"
  ],
  "alcohol": "0 units / week (alcohol-free)",
  "exercise": "Swimming 1x/week",
  "ipss": "IPSS score: 4/35 (mild LUTS)",
  "admin": "Patient anxious about procedures — allocate extra consult time.",
  "mri_hospital": "Maastricht UMC+",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_aed2e170b8e6
Task: 1

Encounter: Urology - outpatient on 12 Jan 2025.
Referrer: Dr. R. van den Berg (GP).
Type: Re-evaluation - prior PCa diagnosis.

Clinical data (read-only — values loaded from the record):
  - 73-year-old male
  - PSA: 86.0 ng/mL
  - mpMRI — PI-RADS score: 5 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 2.306 ng/mL²
  - PSA velocity: 14.92 ng/mL/yr
  - Prior PSA: 57.4 ng/mL
  - Prostate volume: 37.29 mL
  - Months since last PSA: 1
  - DRE findings: Nodus (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Positive (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.9527162 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Not reported
  - Problem list / PMHx: none recorded
  - Current medication: None
  - Allergies: NKA
  - Additional notes: PSA 86 ng/mL. PI-RADS 5. PSAD 2.31. Prostate volume 37 mL. DRE nodus. csPCa 0.95.

Vitals: weight 84 kg, height 181 cm, BMI 25.6, BP 111/74 mmHg, HR 72 bpm. Smoking: Non-smoker.

Chief complaint: Specialist assessment required after confirmed malignancy and subsequent PSA elevation.

History: A 73-year-old warehouse manager seeks specialist guidance following prolonged urological tracking. He is married and resides in an independent unit within a retirement community. He is a non-smoker. Lower urinary tract complaints remain minimal, yielding a 4/35 IPSS score. Despite significant anxiety surrounding invasive diagnostics, he requests thorough consultations. His medical history contains no comorbidities, and he takes no active medication, aside from a minor knee arthroscopy more than ten years ago and a recent dermatology check for actinic keratosis monitoring. He explicitly denies bone discomfort, unexplained weight reduction, or blood in the urine.

Physical examination: DRE — texture: firm; mobility: fixed; asymmetry: palpable nodus in the right lobe. The remaining abdominal and cardiovascular survey shows no anomalies. Vital signs record 111/74 mmHg with a steady pulse of 72 bpm. He demonstrates adequate perfusion and preserves standard functional capacity.

Patient info: warehouse manager; Married; Lives in retirement community (independent unit).
Next of kin: Adult son (primary contact).

Lifestyle: alcohol 0 units / week (alcohol-free); exercise Swimming 1x/week; IPSS score: 4/35 (mild LUTS).

Recent other appointments: Dermatology — actinic keratosis check.
Admin: Patient anxious about procedures — allocate extra consult time.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: NO BIOPSY   p(biopsy) = 0.43
  uncertainty  +/- 0.16 epistemic (95% band 0.12-0.73); among patients I cannot tell apart the outcome was 0.99 of 1.00 mixed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; the levels are what moved my prediction across the series, not what a urologist would mark)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  comorbidity = none recorded (21% of my signal; from pmhx_hypercholesterolaemia, n_comorbidities)
  noted      age = 73 (2% of my signal; from age) · DRE = Nodus (10% of my signal; from dre_suspicious) · PSA = 86 ng/mL (3% of my signal; from log_psa, psav) · prostate volume = 37.29 mL (1% of my signal; from log_vol, vol) · PSA density = 2.306 (0% of my signal; from psad_calc, log_psad) · csPCa probability = 0.95 (1% of my signal; from cspca) · PI-RADS = 5 (20% of my signal; from pirads_ge4, pirads_ge3)
  not used   family history
CONFIDENCE: uncertain — 'discuss' tier; out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

I read 39 raw variables, all from the panel — nothing from the mpMRI prose, the PSA
trajectory, the previous notes or the laboratory. Out-of-fold over 91 labelled cases: AUC
0.758, balanced accuracy 0.625.
The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: prior positive biopsy. My criterion answers DEFER.

The criterion: PSA >= 20 ng/mL in a man with a tissue diagnosis: the next step is staging and treatment, not more tissue. In the labelled series this criterion matched the reading urologist in 5 of 6 cases in exactly this situation.

Like Expert 1, I have read ONLY the visible panel — not the mpMRI prose, the PSA trajectory, the
previous notes or the laboratory panel. Departing from me needs a specific finding from a document
somebody actually opened, named out loud; not a restatement of the panel numbers I already used.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; 'decisive' marks the variable the rule turns on)
  decisive   PSA = 86 ng/mL
  important  prior biopsy = Positive
  noted      age = 73 · DRE = Nodus · prostate volume = 37.29 mL · PSA density = 2.306 · PI-RADS = 5 · comorbidity = none recorded
  not used   family history, csPCa probability
CONFIDENCE: uncertain — the rule matched the reading urologist in only 5 of 6 labelled cases

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 49 labelled men in this same situation (Positive prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 0.93: PI-RADS 5, PSA 113.0, PSAD 2.61, age 67, DRE Nodus -> DEFER (clear). He wrote: "Patient has a verified PCa with PSA 113. Start treatment and do I PSMA-PET for further workup."
  2. distance 1.10: PI-RADS 5, PSA 187.0, PSAD 3.26, age 75, DRE Nodus -> BIOPSY (clear). He wrote: "Very High PSA. Most likely metastatic"
  3. distance 1.50: PI-RADS 5, PSA 190.0, PSAD 4.097, age 66, DRE Nodus -> DEFER (clear). He wrote: "Patient with a clear PCa diagnosis. Do PSMA-PET and start hormontreatment"

PRECEDENT: DEFER (weighted vote 0.34 for biopsy). Distance-weighted precedent is no better than chance here (0.47 leave-one-out): read the precedents for how this urologist reasons, not for the answer.

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

WHAT THE READING UROLOGIST WEIGHED IN THESE PRECEDENTS — in the form's vocabulary, with this man's values (weighted majority of the 3 nearest labelled traces; the distance itself is on PI-RADS, prior biopsy first)
  decisive   prior biopsy = Positive · PSA = 86 ng/mL · PI-RADS = 5
  noted      family history = not opened (0 of 91) · age = 73 · DRE = Nodus · prostate volume = 37.29 mL · PSA density = 2.306 · comorbidity = none recorded
  not used   csPCa probability
CONFIDENCE: uncertain — in this situation the library is no better than chance (47% out of fold)

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 49 labelled traces in this situation (Positive prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes.

WHAT HE WEIGHS — in the form's vocabulary, with this man's values (these are the levels that go on the form, unless a colleague shows a reason to move one)
  decisive   prior biopsy = Positive · PI-RADS = 5
  important  age = 73 · PSA = 86 ng/mL
  noted      family history = not opened (0 of 91) · DRE = Nodus · prostate volume = 37.29 mL · PSA density = 2.306 · comorbidity = none recorded
  not used   csPCa probability
CONFIDENCE: clear — the level the reading urologist records in this situation, from his labelled traces

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
"linking PI-RADS score (1-2, 3, and 4-5) to PSA-D categories (< 0.10, 0.10-0.15, 0.15-0.20 and > 0.20ng/mL) (Table 5.5) [230]. This risk-adapted matrix table may guide the decision to perform a biopsy."
The guideline suggests using the PI-RADS score and PSA density to guide the decision to perform a biopsy. For this patient, the PI-RADS score is 5 and the PSA density is 2.306 ng/mL², which falls into the highest risk category according to the retrieved table.

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, your variable 'prior biopsy = Positive' is decisive, whereas the guideline treats this as context; the guideline requires the PI-RADS score and PSA density to guide the decision. The guideline suggests that for a PI-RADS 5 and PSA density > 0.20 ng/mL/cc, a biopsy may be indicated based on the risk matrix. The guideline needs the comparison MRI to determine if a repeat biopsy is warranted.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the prior biopsy status: Positive means the guideline suggests staging and treatment, not more tissue; if it is unrecorded the indication stands
radiology_report - whether the lesion is compared against an earlier study: unchanged does not support re-sampling, new or larger does
psa_trend - the PSA trend: the guideline suggests using PSA density to determine risk; if the trend is not provided, the guideline requires the PSA density value.
laboratory_results - the laboratory results: the guideline makes decisive the PSA density value, which is 2.306 ng/mL², placing the patient in the highest risk category.

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

This case hinges on whether the prior positive biopsy status overrides the high-risk imaging features according to the EAU guideline.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Does the radiology report indicate whether the lesion is compared against an earlier study?
  psa_trend (get_psa_trend) -> What is the PSA trend, as the guideline requires this information to determine risk?
  previous_notes (get_previous_notes) -> What is the GRADE of the prior biopsy and is there a surveillance protocol in place?

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the GRADE of the prior biopsy as documented in the previous notes?
  Q2. Does the radiology report indicate if the lesion is compared against an earlier study?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
The radiology report indicates that the lesion is compared against an earlier study, as it states: "Post-contrast dynamics demonstrate prompt, localized hyperenhancement compared to adjacent tissue."
psa_trend
The PSA trend shows a rise from 2.7 ng/mL in Aug 2023 to 12.2 ng/mL in May 2024, and a further rise to 86.0 ng/mL in Jan 2025.
previous_notes
The GRADE of the prior biopsy is not explicitly stated, but the notes mention "initial positive biopsy" and "warranting continued monitoring." There is no explicit surveillance protocol mentioned.

WHAT I DID NOT OPEN
laboratory_results, family-history anamnesis, pathology report.

WHAT THIS SUPPORTS
FOR sampling this patient now
The PI-RADS score of 5 and PSA density of 2.306 ng/mL² place the patient in the highest risk category according to the EAU guideline.
The PSA trend shows a significant, rapid escalation in PSA levels, culminating in 86.0 ng/mL.
AGAINST sampling this patient now
The previous notes suggest that a positive biopsy has already occurred, which the guideline suggests leads to staging and treatment rather than further tissue sampling.

WHERE THIS LEANS
LEAN: defer

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: INDETERMINATE (uncertain). Last value 86.00 ng/mL over 3 points spanning 17 months; velocity +57.84 ng/mL per year; doubling time about 3 months.
PROJECTION at 6 months: 80.5 ng/mL, conformal 95% band 23.1-280.4.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (the serial PSA only)
  noted      PSA = 86 ng/mL
  not used   prior biopsy, family history, age, DRE, prostate volume, PSA density, csPCa probability, PI-RADS, comorbidity
CONFIDENCE: uncertain — the conformal band does not clear the last value

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report — the laboratory panel was not opened, so that block is imputed and my band is wider for it; nothing from the previous notes or the PSA series.

SUGGESTION: NO BIOPSY   p(biopsy) = 0.47
  uncertainty  +/- 0.13 epistemic (95% band 0.21-0.73), of which 0.01 comes from values that had to be imputed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 59% of the time over the 29 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel + the documents that were opened; PI-RADS here means the report's own wording — DWI restriction, lesion size — not the score)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  PI-RADS = 5 (22% of my signal; from rad_dwi_restriction, rad_lesion_ge15mm)
  noted      PSA = 86 ng/mL (21% of my signal; from fpsa_lt15, psa_delta_prev) · prostate volume = 37.29 mL (4% of my signal; from log_vol, vol) · PSA density = 2.306 (0% of my signal; from psad_calc) · comorbidity = none recorded (4% of my signal; from n_comorbidities, on_alpha_blocker)
  not used   family history, age, DRE, csPCa probability
CONFIDENCE: uncertain — 'discuss' tier; out-of-fold it was right 59% of the time over the 29 labelled cases in this tier

Out-of-fold AUC 0.794. I am the only expert that has read the report's
wording, and I still cannot see the prior grade or the surveillance history: those are in the notes, and
the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  DEFER, p(biopsy)=0.43  ('discuss' tier; weight 1.0)
  EXPERT-FUSION      DEFER, p(biopsy)=0.47  ('discuss' tier, fusion_nolab; weight 1.5)
  EXPERT-LIBRARY     DEFER, p(biopsy)=0.34  (k=3 precedents; does not vote)
  EXPERT-COHORT      DEFER  (rule psa_ge_20; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: cohort criterion (psa_ge_20) — carried by EXPERT-COHORT.
PANEL ANSWER: NO BIOPSY. It matched the reading urologist in 5 of 6 labelled cases in exactly this situation (prior positive biopsy).

THE BOARD'S VARIABLES — value · what each expert marked · what goes on the form
  bx           Positive                     E1:DEC E3:DEC cohort:IMP library:DEC E2:—            -> decisive
  fh           not opened (0 of 91)         E1:— E3:— cohort:— library:not E2:—                  -> not_used (raised from noted by the board)
  age          73                           E1:not E3:— cohort:not library:not E2:—              -> important
  dre          Nodus                        E1:not E3:— cohort:not library:not E2:—              -> not_used (raised from noted by the board)
  psa          86 ng/mL                     E1:not E3:not cohort:DEC library:DEC E2:not          -> important
  vol          37.29 mL                     E1:not E3:not cohort:not library:not E2:—            -> noted
  psad         2.306                        E1:not E3:not cohort:not library:not E2:—            -> noted
  cspca        0.95                         E1:not E3:— cohort:— library:— E2:—                  -> not_used
  pirads       5                            E1:not E3:IMP cohort:not library:DEC E2:—            -> decisive
  comorbidity  none recorded                E1:IMP E3:not cohort:not library:not E2:—            -> noted
  (DEC decisive · IMP important · not noted · — not used; the last column is the level recorded, from the trace of the reading urologist)

Confidence to record: clear.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents the registrar opened (radiology_report, psa_trend, previous_notes) have answered the moderator's questions.

ALIGNMENT WITH THE PANEL
The retrieved evidence supports the PANEL-PROTOCOL's answer of NO BIOPSY, as the cohort criterion (PSA $\ge$ 20 ng/mL) fired, and the previous notes indicated a positive biopsy.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What is the GRADE of the prior biopsy as documented in the previous notes? The previous notes state "initial positive biopsy" and mention "warranting continued monitoring," but do not explicitly state a GRADE.
Q2. Does the radiology report indicate if the lesion is compared against an earlier study? The radiology report states: "Post-contrast dynamics demonstrate prompt, localized hyperenhancement compared to adjacent tissue."

WHAT CARRIES WEIGHT, AND WHY
prior biopsy: Positive (decisive) because the cohort criterion matched the reading urologist in 5 of 6 cases in this exact situation. I would move this to 'decisive' as it is the primary rule that led to the panel's decision.
psa: 86 ng/mL (important) because it was the decisive variable for the cohort criterion firing. I agree with the panel's marking of this as important.
psad: 2.306 (noted) because it was noted by the panel, and it was a key input for the EAU guideline assessment. I agree with the panel's marking of this as noted.
Confidence: clear.

MY SUGGESTION TO THE CHAIR
The panel's position of NO BIOPSY is supported by the cohort criterion firing, despite the high-risk imaging features. The uncertainty regarding the prior biopsy grade (Q1) does not overturn the rule that dictates deferral in this specific context.

VERDICT: ready | SUGGEST: defer | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: NO BIOPSY   (confidence: clear)

73y male, PSA 86 ng/mL, PI-RADS 5, and prior positive biopsy. High PSA and PI-RADS 5 outweigh the prior diagnosis, suggesting staging and treatment over repeat biopsy. No prior biopsy grade recorded, but high PSA dictates proceeding to definitive management. Plan is staging and treatment.

What carried weight: bx=decisive, age=important, psa=important, vol=noted, psad=noted, pirads=decisive, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes
